Long-term Morbidity of Testicular Cancer Treatment




Key points








  • Potentially long-term life-threatening complications, including second malignant neoplasms, cardiovascular disease, neurotoxicity and ototoxicity, pulmonary complications, hypogonadism, and nephrotoxicity have accompanied the remarkable successes of testicular cancer treatment.



  • Testicular cancer survivors should follow applicable national guidelines for cancer screening and management of cardiovascular risk factors.



  • Health care providers should capitalize on the time of testicular cancer diagnosis as a teachable moment to introduce and promote lifestyle changes in testicular cancer survivors, including smoking cessation, better nutrition, and participation in a regular exercise regimen.



  • Testicular cancer is positioned to become a paradigm in survivorship research for adult-onset cancer and the most comprehensive multi-institutional study to date is currently underway to examine genetic variants associated with long-term toxicities of platinum-based chemotherapy in testicular cancer survivors.


Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Mar 3, 2017 | Posted by in UROLOGY | Comments Off on Long-term Morbidity of Testicular Cancer Treatment

Full access? Get Clinical Tree

Get Clinical Tree app for offline access